- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Merck Launches Campaign to Support UK Carers
Merck, Darmstadt, Germany has announced that its Embracing Carers™ initiative has launched a new campaign to help individuals in the UK reflect and recognize their unpaid caring role sooner and access available support and resources faster. Developed by Merck, Darmstadt, Germany and guided by Carers UK and other leading international carer organizations, Embracing Carers™ is a global movement to highlight the important role of carers in society. With up to 6,000 people a day in the UK becoming carers, Embracing Carers has launched the “By Day, By Night initiative”. The campaign aims to help individuals reflect on their daily lives and help those in the UK recognize their role as a carer. 6.5 million people (around 10 per cent of the UK population) are carers and the majority take a long time to recognize their caring role. Research by Carers UK shows that over half (54%) of carers in the country took over a year to recognize their caring role and nearly a quarter (24%) took over five years to recognize their role as a carer.
Fierce Females in the Life Science Space
March 29th 2024In this week’s episode, in recognition of international women’s month, Editor Miranda Schmalfuhs has compiled audio clips from interviews with female KOLs that she's been fortunate enough to speak with over this past month for content across a few of our brands.
FDA Approves Stelara Biosimilar Selarsdi to Treat Psoriasis, Psoriatic Arthritis
April 17th 2024Alvotech’s and Teva's Selarsdi (ustekinumab-aekn), the second FDA-approved biosimilar to Stelara, is indicated to treat patients aged 6 years and above with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy and for patients aged 6 years and above with active psoriatic arthritis.
